Fundamental dimension Equity attribute | ALOTPeer $28.990.00% Cap $227.3MP/E -165.2x QuantScore50/100 | AMPGLeader $2.58▼-3.20% Cap $77.58MP/E -7.6x QuantScore55/100 | INVEPeer $2.79▲+2.20% Cap $67.62MP/E -4.3x QuantScore53/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
50/100 |
46/100 |
65/100 |
Valuation Multiples, PEG & DCF upside | 19/100 | 0/100 | 75/100 |
Health Piotroski, Altman Z, leverage & liquidity | 51/100 | 61/100 | 59/100 |
Growth Revenue / earnings growth & margins | 29/100 | 67/100 | 0/100 |
Sentiment Analyst ratings, targets & revisions | 100/100 | 100/100 | 66/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -165.2x | -7.6x | -4.3x |
Forward P/E (next FY) | 26.6x | -9.9x | -5.3x |
EV / EBITDA (TTM) | 40.1x | -11.8x | 3.9x |
Price / Sales | 1.5x | 3.2x | 2.8x |
Price / Free Cash Flow | 22.6x | -5.5x | -7.3x |
PEG ratio | -1.09 | -0.09 | 0.03 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 6 / 9 | 2 / 9 | 3 / 9 |
Altman Z-Score | 4.08 (Safe) | 3.60 (Safe) | 2.57 (Grey) |
Total debt / equity | 0.49 | 0.08 | 0.01 |
Quick ratio | 0.7x | 2.6x | 19.0x |
Interest coverage | 0.8x | — | — |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -0.5% | +165.0% | -19.3% |
Net income growth YoY | +83.6% | +37.7% | -124.1% |
Gross margin (TTM) | 33.9% | 33.6% | 15.9% |
Operating margin (FY) | 1.0% | -29.1% | -96.0% |
FCF margin (FY) | 7.6% | -38.5% | -36.4% |
5. Trailing price performancePrice change over period |
1M return | 0.0% | -25.1% | +17.7% |
3M return | +1.9% | -52.4% | +3.7% |
6M return | +224.3% | +32.1% | -36.2% |
Year to date | +235.1% | -13.9% | -27.3% |
1Y return | +183.9% | -24.3% | -29.4% |
3Y return | +135.7% | +42.5% | -59.0% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $4.61 -84.1% premium | $-75.36 -3026.7% premium | $4.94 +77.1% upside |
Wall Street consensus target | — — | — — | $3.40 +21.9% · range $3.10–$4.00 |
Consensus stance | 100% Buy0% Hold0% Sell | 100% Buy0% Hold0% Sell | 71% Buy29% Hold0% Sell |